Nayab Mustansar* and Rizwan Rafi
Consultant Nuclear Physician, Department of Nuclear Medicine, Islamabad, Pakistan
*Corresponding Author: Nayab Mustansar, Consultant Nuclear Physician, Department of Nuclear Medicine, Islamabad, Pakistan.
Received: April 30, 2020; Published: May 02, 2019
As of February 2020, new cases of COVID19 have been reported in Pakistan, Sindh province initially and then spread to the rest of provinces due to the Foreigners coming back to Pakistan [1]. At present unfortunately no vaccine has been developed moreover we don’t have any specific anti-viral for this novel corona virus [2-4]. Three general methods, which include existing broad-spectrum antiviral drugs using standard assays, screening of a chemical library containing many existing compounds or databases, and the redevelopment of new specific drugs based on the genome and biophysical understanding of individual coronaviruses, are used to discover the potential antiviral treatment of human pathogen coronavirus [5-8]. Although till now the patients are being treated on symptomatic basis. Moreover, immune boosting drugs and diet has also been added and have shown positive results too.
Keywords:Treatment; Analgesics; Antibiotics; Antivirals; Immune Boosters; Coronavirus; Pneumonia
Citation: Nayab Mustansar and Rizwan Rafi. “Treatment Options for Novel Corona Virus-Current guidelines in Clinical Settings of Pakistan". Acta Scientific Pharmaceutical Sciences 4.6 (2020): 01-02.
Copyright: © 2020 Nayab Mustansar and Rizwan Rafi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Copyright